Hyperlipidemia Market to Register Immense Growth, Predicts DelveInsight | Key Companies in the Market - Amgen, Eli Lilly and Company, AstraZeneca, Arrowhead, Pfizer, Regeneron, Sanofi, AbbVie, GlaxoSmithKline New York, USA, June 28, 2023 (GLOBE NEWSWIRE) -- Hyperlipidemia Market to Register Immense Growth, Predicts DelveInsight | Key Companies in the Market - Amgen, Eli Lilly and Company, AstraZeneca,...

Antihyperlipidemic Drugs Market to Hit USD 20.1 Bn by 2031 | Transparency Market Research Wilmington, Delaware, United States, March 27, 2023 (GLOBE NEWSWIRE) -- According to the exhaustive antihyperlipidemic drugs market report by TMR, the global industry was valued USD 12.0 Bn in 2022...

$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...

Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018 CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Shifa Biomedical Corporation (Shifa), a drug discovery biopharmaceutical company focused on developing novel agents to treat cardiovascular disease and...

Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...